Latest News about GILD
Recent news which mentions GILD
Gilead Withdraws Use Of Zydelig In Two Forms Of Blood Cancer In US
January 18, 2022
Tickers
GILD
From Benzinga
3 Pharma Stocks With Especially Juicy Dividends
January 16, 2022
From Motley Fool
2 Top Healthcare Stocks to Buy Right Now
January 14, 2022
From Motley Fool
4 Biotech Acquisitions We'd Like to See in 2022
January 14, 2022
From Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
January 12, 2022
From Benzinga
7 Safe Stocks for Your Retirement
January 07, 2022
From InvestorPlace
This ‘cash cow’ value-stock strategy can fatten your portfolio even if you fear the Fed
January 06, 2022
From MarketWatch
What 5 Analyst Ratings Have To Say About Gilead Sciences
January 06, 2022
Tickers
GILD
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2022
January 06, 2022
From Benzinga
10 Biggest Price Target Changes For Thursday
January 06, 2022
From Benzinga
7 Pharmaceutical Stocks That Could Make You Rich
January 06, 2022
From InvestorPlace
2 Top Dividend Stocks That Are Yielding More Than 3%
January 05, 2022
From Motley Fool
23 dividend stocks that can pass this strict quality screen
January 04, 2022
From MarketWatch
3 Biotech Stocks That Could Double in 2022
January 03, 2022
From Motley Fool
Two Paths to End the Pandemic but the Hybrid Approach Looks Dominant
December 29, 2021
From Benzinga
NRXP Stock Alert: What Is Going on With NRx Pharmaceuticals Today?
December 29, 2021
From InvestorPlace
Mobile Clinics for Mental Health Treatments Reportedly Launching in Major Cities Across the U.S.
December 28, 2021
From Benzinga
Got $5,000? Buy and Hold These 3 Value Stocks for Years
December 24, 2021
From Motley Fool
The Daily Biotech Pulse: Novartis Snags Twin FDA Nods, Novavax Positive Vaccine News Continues, Arcutis Psoriasis Application Accepted For Review
December 23, 2021
From Benzinga
Gilead's Remdesivir Shows Consistent Efficacy In Patients With Comorbidities With Higher Risk for Severe COVID-19
December 23, 2021
Tickers
GILD
From Benzinga
FDA Slaps Clinical Hold On Gilead's Injectable Lenacapavir In HIV Trials
December 22, 2021
Tickers
GILD
From Benzinga
The Daily Biotech Pulse: Allakos Slips Negative Late-Stage Data, Pfizer & Merck Announce Fresh COVID Pill Deal With UK, Regulatory Setback For Takeda
December 22, 2021
From Benzinga
European Commission Expands Use Of Remdesivir In COVID-19 Patients Not On Supplemental Oxygen
December 21, 2021
Tickers
GILD
From Benzinga
From Benzinga
Gilead's CAR-T Yescarta Shows 78% Complete Response Rate In First-Line Lymphoma Patients
December 14, 2021
Tickers
GILD
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 9, 2021
December 09, 2021
From Benzinga
Why Arcus Biosciences Stock Vaulted Higher in November
December 09, 2021
From Motley Fool
Is Gilead Sciences Stock a Buy Now?
December 07, 2021
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.